Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:03PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 282.79B |
| Enterprise value | 293.94B |
| Trailing P/E | 11.35 |
| Forward P/E | 7.40 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.13 |
| Price/book (mrq) | 3.43 |
| Enterprise value/revenue | 3.18 |
| Enterprise value/EBITDA | 8.62 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.71 |
| 52-week change 3 | 31.80% |
| S&P500 52-week change 3 | -7.05% |
| 52-week high 3 | 61.71 |
| 52-week low 3 | 38.48 |
| 50-day moving average 3 | 51.32 |
| 200-day moving average 3 | 49.82 |
Share statistics
| Avg vol (3-month) 3 | 28.09M |
| Avg vol (10-day) 3 | 25.07M |
| Shares outstanding 5 | 5.61B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 5.61B |
| % held by insiders 1 | 0.04% |
| % held by institutions 1 | 69.40% |
| Shares short (28 Apr 2022) 4 | 67.99M |
| Short ratio (28 Apr 2022) 4 | 2.71 |
| Short % of float (28 Apr 2022) 4 | 1.20% |
| Short % of shares outstanding (28 Apr 2022) 4 | 1.20% |
| Shares short (prior month 30 Mar 2022) 4 | 61.56M |
Dividends & splits
| Forward annual dividend rate 4 | 1.6 |
| Forward annual dividend yield 4 | 3.16% |
| Trailing annual dividend rate 3 | 1.57 |
| Trailing annual dividend yield 3 | 3.10% |
| 5-year average dividend yield 4 | 3.64 |
| Payout ratio 4 | 35.36% |
| Dividend date 3 | 09 June 2022 |
| Ex-dividend date 4 | 11 May 2022 |
| Last split factor 2 | 1054:1000 |
| Last split date 3 | 16 Nov 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 02 Apr 2022 |
Profitability
| Profit margin | 27.01% |
| Operating margin (ttm) | 34.66% |
Management effectiveness
| Return on assets (ttm) | 11.69% |
| Return on equity (ttm) | 33.59% |
Income statement
| Revenue (ttm) | 92.43B |
| Revenue per share (ttm) | 16.48 |
| Quarterly revenue growth (yoy) | 76.80% |
| Gross profit (ttm) | 50.63B |
| EBITDA | 37.12B |
| Net income avi to common (ttm) | 25.41B |
| Diluted EPS (ttm) | 4.36 |
| Quarterly earnings growth (yoy) | 61.20% |
Balance sheet
| Total cash (mrq) | 23.9B |
| Total cash per share (mrq) | 4.26 |
| Total debt (mrq) | 36.44B |
| Total debt/equity (mrq) | 44.07 |
| Current ratio (mrq) | 1.39 |
| Book value per share (mrq) | 14.74 |
Cash flow statement
| Operating cash flow (ttm) | 34.58B |
| Levered free cash flow (ttm) | 34.29B |
© 2022 Yahoo. All rights reserved.
